Trial intelligence / Profile preview

Imiquimod 5% cream versus vehicle before ablative therapy for external anogenital warts

2004-004654-19Phase 4Completed

Sponsor
3M
Start
Nov 2005
Modality
Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of imiquimod in anogenital warts, sponsored by 3M. Started Nov 2005; status: completed.

02

Drugs

imiquimod
03

Conditions

anogenital warts

Beyond the preview

Go deeper on 2004-004654-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-004654-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call